EKSO BIONICS HOLDINGS, INC. — Investor Relations & Filings

Ekso Bionics Holdings, Inc. is a developer of robotic exoskeleton technology designed to augment human strength, endurance, and mobility. The company's primary focus is on the medical market, providing solutions for rehabilitation and personal use. Its products assist individuals with lower-extremity paralysis or weakness resulting from conditions such as spinal cord injury (SCI), stroke, acquired brain injury, and multiple sclerosis. Key offerings include the EksoNR, an FDA-cleared exoskeleton for clinical rehabilitation; Ekso Indego Therapy for outpatient settings; and the Ekso Indego Personal, a lightweight system that enables individuals with SCI to stand and walk in home and community environments. The company also develops technology for industrial applications.